Earnings call Dr. Lal PathLabs reported Q3 FY26 revenue of ₹660 crore, up 10.6% YoY, supported by a 7.7% rise in revenue per patient. EBITDA margin (pre-exceptional) improved to 27.2%. While patient ...
Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...
Earnings call Dr. Lal PathLabs reported Q1 FY26 revenue of ₹670 crore, up 11.3% YoY, with PAT growing 24.3% to ₹134 crore. EBITDA margin held strong at 28.7%. Management reaffirmed 11–12% full-year ...
Jan 30 (Reuters) - Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to India’s new labour code, despite strong demand for its bundled test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results